(Q44788451)
Statements
VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528 (English)
Anne-Marie Dingemans
Susanne Crowe
Solange Peters
Heinrich Roder
Julia Grigorieva
Joanna Roder
Francesco Zappa
Miklos Pless
Florent Baty
Lukas Bubendorf
Shu-Fang Hsu Schmitz
Kyung-Jae Na
David Carbone
Rolf Stahel
Egbert Smit
1 November 2012